Clinical trial · Observational
Allocating Resources for Cancer Care in Times of the Sars-CoV-2 Outbreak. Health Care Research
Medical Care of Cancer Patients During the COVID-19 Pandemic - an Analysis of Health Insurance Claims Data
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The focus on treatment of COVID19 patients during the Sars-CoV-2 outbreak has most likely implications for the extent and quality of diagnosis and treatment of non-COVID19 patients. Medical care of cancer patients is a particularly sensitive area. To draw holistic conclusions, it is necessary to analyze the provision of healthcare as broadly as possible with regard to the dimensions of access, processes and outcome during the Sars-CoV-2 pandemic. This will be implemented exemplarily for the early detection, diagnosis and treatment of colorectal cancer (CRC) and pancreatic cancer (PaCa) in Saxony. Patients with diagnosis, treatment or early detection measures for type 2 diabetes (T2D), coronary heart disease (CHD) and multiple sclerosis (MS) serve as comparison groups.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Colorectal Cancer (CRC) and Pancreatic Cancer (PaCa) | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Sars-CoV-2 outbreak | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (2)
- measure
- Number of confirmed diagnoses (new cases of CRC or PaCa)
- timeFrame
- Comparison of 2019 to 2020
- measure
- Number of colonoscopies
- timeFrame
- Comparison of 2019 to 2020
Secondary outcomes (2)
- measure
- Number of hospitalizations
- timeFrame
- Comparison of 2019 to 2020
- measure
- Number of surgeries/systemic therapies related to cancer after onset of disease
- timeFrame
- Comparison of 2019 to 2020
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 4 Years
Show eligibility criteria text
Inclusion Criteria: * Resident of Saxony, Germany with health insurance coverage provided by AOK PLUS * Diagnosis of colorectal cancer, pancreatic cancer, type 2 diabetes, coronary heart disease or multiple sclerosis between in 2019 or 2020 according to ICD-10 Exclusion Criteria: * Change of health insurance provider between 2015 and 2020 * Born after 2014 * Deceased between 2015-2018
References
Publications (0)
Data not yet available